{"nct_id":"NCT02152956","title":"Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)","status":"TERMINATED","status_verified_date":"2024-01","start_date":"2014-06-09","start_date_type":"ACTUAL","primary_completion_date":"2022-07-05","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-05","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MGNX"]}